Immunomodulation with Recombinant Interferon-γ1b in Pulmonary Tuberculosis

BACKGROUND: Current treatment regimens for pulmonary tuberculosis require at least 6 months of therapy. Immune adjuvant therapy with recombinant interferon-γ1b (rIFN-γb) may reduce pulmonary inflammation and reduce the period of infectivity by promoting earlier sputum clearance. METHODOLOGY/PRINCIPA...

詳細記述

保存先:
書誌詳細
主要な著者: Dawson, Rod, Condos, Rany, Tse, Doris, Huie, Maryann L., Ress, Stanley, Tseng, Chi-Hong, Brauns, Clint, Weiden, Michael, Hoshino, Yoshihiko, Bateman, Eric, Rom, William N.
フォーマット: Artigo
言語:Inglês
出版事項: Public Library of Science 2009
主題:
Research Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC2737621/
https://ncbi.nlm.nih.gov/pubmed/19753300
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0006984
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料